231 related articles for article (PubMed ID: 34023100)
21. GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors.
Choo F; Rakheja D; Davis LE; Davare M; Park JY; Timmons CF; Neff T; Beadling C; Corless CL; Davis JL
Genes Chromosomes Cancer; 2021 Sep; 60(9):623-630. PubMed ID: 34036664
[TBL] [Abstract][Full Text] [Related]
22. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
23. Myxoid Spindle Cell Sarcoma With
So YK; Chow C; To KF; Chan JKC; Cheuk W
Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
[TBL] [Abstract][Full Text] [Related]
24. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
Andrei V; Haefliger S; Baumhoer D
Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
[TBL] [Abstract][Full Text] [Related]
26. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
27. Expanding the differential of superficial tumors with round-cell morphology: Report of three cases of CIC-rearranged sarcoma, a potentially under-recognized entity.
Maloney N; Smith SM; Peters SB; Batistatou A; Evangelou Z; Harms PW; Chan MP; Antonescu CR; Linos K
J Cutan Pathol; 2020 Jun; 47(6):535-540. PubMed ID: 31886887
[TBL] [Abstract][Full Text] [Related]
28. Superficial CD34-Positive Fibroblastic Tumor.
Perret R; Hostein I
Surg Pathol Clin; 2024 Mar; 17(1):1-12. PubMed ID: 38278599
[TBL] [Abstract][Full Text] [Related]
29. [EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis].
Su HY; Zhao L; Ji G; Yao QL; Bai QM; Zhou XY; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):19-24. PubMed ID: 36617901
[No Abstract] [Full Text] [Related]
30. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.
Italiano A; Sung YS; Zhang L; Singer S; Maki RG; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2012 Mar; 51(3):207-18. PubMed ID: 22072439
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration cytology of a superficial CD34-positive fibroblastic tumour, including differential diagnoses and recent updates.
Rekhi B
Cytopathology; 2023 Jan; 34(1):66-71. PubMed ID: 36151940
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.
Papke DJ; Hornick JL
Histopathology; 2022 Jan; 80(1):216-232. PubMed ID: 34958499
[TBL] [Abstract][Full Text] [Related]
33. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
34. NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation.
Overfield CJ; Edgar MA; Wessell DE; Wilke BK; Garner HW
Skeletal Radiol; 2022 Aug; 51(8):1707-1713. PubMed ID: 35031835
[TBL] [Abstract][Full Text] [Related]
35. The New Kids on the Block: Recently Characterized Soft Tissue Tumors.
Riddle NN; Gardner JM
Surg Pathol Clin; 2015 Sep; 8(3):467-91. PubMed ID: 26297066
[TBL] [Abstract][Full Text] [Related]
36. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
37. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.
Yoshida A; Wakai S; Ryo E; Miyata K; Miyazawa M; Yoshida KI; Motoi T; Ogawa C; Iwata S; Kobayashi E; Watanabe SI; Kawai A; Mori T
Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal skin tumors - Novel entities in the 5th edition of WHO classification of skin tumors.
Michal M
Cesk Patol; 2024; 60(1):49-58. PubMed ID: 38697827
[TBL] [Abstract][Full Text] [Related]
39. Advances in the clinicopathological and molecular classification of cutaneous mesenchymal neoplasms.
Costigan DC; Doyle LA
Histopathology; 2016 May; 68(6):776-95. PubMed ID: 26763770
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal Tumors with EWSR1 Gene Rearrangements.
Thway K; Fisher C
Surg Pathol Clin; 2019 Mar; 12(1):165-190. PubMed ID: 30709442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
